Department of Medicine, University of California, San Francisco, San Francisco California; Medical Service, San Francisco Veterans Affairs Health Care System, San Francisco California.
Department of Medicine, University of California, San Francisco, San Francisco California.
J Heart Lung Transplant. 2023 Dec;42(12):1700-1709. doi: 10.1016/j.healun.2023.08.018. Epub 2023 Aug 28.
Primary graft dysfunction (PGD) is a major risk factor for chronic lung allograft dysfunction (CLAD) following lung transplantation, but the mechanisms linking these pathologies are poorly understood. We hypothesized that the replicative stress induced by PGD would lead to erosion of telomeres, and that this telomere dysfunction could potentiate CLAD. In a longitudinal cohort of 72 lung transplant recipients with >6 years median follow-up time, we assessed tissue telomere length, PGD grade, and freedom from CLAD. Epithelial telomere length and fibrosis-associated gene expression were assessed on endobronchial biopsies taken at 2 to 4 weeks post-transplant by TeloFISH assay and nanoString digital RNA counting. Negative-binomial mixed-effects and Cox-proportional hazards models accounted for TeloFISH staining batch effects and subject characteristics including donor age. Increasing grade of PGD severity was associated with shorter airway epithelial telomere lengths (p = 0.01). Transcriptomic analysis of fibrosis-associated genes showed alteration in fibrotic pathways in airway tissue recovering from PGD, while telomere dysfunction was associated with inflammation and impaired remodeling. Shorter tissue telomere length was in turn associated with increased CLAD risk, with a hazard ratio of 1.89 (95% CI 1.16-3.06) per standard deviation decrease in airway telomere length, after adjusting for subject characteristics. PGD may accelerate telomere dysfunction, potentiating immune responses and dysregulated repair. Epithelial cell telomere dysfunction may represent one of several mechanisms linking PGD to CLAD.
原发性移植物功能障碍 (PGD) 是肺移植后慢性肺移植物功能障碍 (CLAD) 的主要危险因素,但将这些病变联系起来的机制尚不清楚。我们假设 PGD 引起的复制应激会导致端粒侵蚀,而这种端粒功能障碍可能会增强 CLAD。在一项纵向队列研究中,我们纳入了 72 名肺移植受者,中位随访时间超过 6 年,评估了组织端粒长度、PGD 分级和 CLAD 无进展情况。在移植后 2 至 4 周,通过 TeloFISH 检测和 nanoString 数字 RNA 计数,评估了支气管内活检标本的上皮端粒长度和纤维化相关基因的表达。负二项混合效应和 Cox 比例风险模型考虑了 TeloFISH 染色批次效应和包括供体年龄在内的受试者特征。PGD 严重程度等级的增加与气道上皮端粒长度缩短相关(p=0.01)。纤维化相关基因的转录组分析显示,在从 PGD 中恢复的气道组织中,纤维化途径发生改变,而端粒功能障碍与炎症和受损的重塑有关。组织端粒长度缩短反过来与 CLAD 风险增加相关,气道端粒长度每标准偏差降低,风险比为 1.89(95%CI 1.16-3.06),调整了受试者特征后。PGD 可能会加速端粒功能障碍,增强免疫反应和失调的修复。上皮细胞端粒功能障碍可能是将 PGD 与 CLAD 联系起来的几种机制之一。